Cargando…
Aucubin slows the development of osteoporosis by inhibiting osteoclast differentiation via the nuclear factor erythroid 2-related factor 2-mediated antioxidation pathway
CONTEXT: Osteoporosis (OP) is a metabolic disease. We have previously demonstrated that aucubin (AU) has anti-OP effects that are due to its promotion of the formation of osteoblasts. OBJECTIVES: To investigate the mechanisms of anti-OP effects of AU. MATERIALS AND METHODS: C57BL/6 mice were randoml...
Autores principales: | Zhang, Yongfeng, Liu, Xin, Li, Yangyang, Song, Minkai, Li, Yutong, Yang, Anhui, Zhang, Yaqin, Wang, Di, Hu, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583775/ https://www.ncbi.nlm.nih.gov/pubmed/34757891 http://dx.doi.org/10.1080/13880209.2021.1996614 |
Ejemplares similares
-
Aucubin exerts anti-osteoporotic effects by promoting osteoblast differentiation
por: Li, Yutong, et al.
Publicado: (2020) -
Correction for: Aucubin exerts anti-osteoporotic effects by promoting osteoblast differentiation
por: Li, Yutong, et al.
Publicado: (2021) -
Nuclear factor erythroid 2–related factor 2 (Nrf2) deficiency causes age-dependent progression of female osteoporosis
por: Kubo, Yusuke, et al.
Publicado: (2022) -
Role of Nuclear Factor Erythroid 2-Related Factor 2 in Diabetic Nephropathy
por: Cui, Wenpeng, et al.
Publicado: (2017) -
Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism
por: Smolková, Katarína, et al.
Publicado: (2020)